GYS2

gene product
The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated within AVI
Eligible for validation within AVI
92 antibodies from 20 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
Novus Biologicals
3 antibodies
Atlas Antibodies
1 antibody
antibodies-online
36 antibodies
LifeSpan BioSciences, Inc.
8 antibodies
Invitrogen Antibodies
2 antibodies
Biorbyt
10 antibodies
OriGene
2 antibodies
Aviva Systems Biology
1 antibody
Creative Diagnostics
2 antibodies
Boster Biological Technology
1 antibody
NovoPro Bioscience Inc.
1 antibody
ProSci
1 antibody
St John's Laboratory
1 antibody
MyBioSource
5 antibodies
Abgent
1 antibody
GeneTex
1 antibody
United States Biological
1 antibody
Abnova Corporation
2 antibodies
Sigma-Aldrich
1 antibody